Copay and patient support programs remain at risk today for ineligible utilization. As patient coverage churns through the year, so does eligibility. Patient access, HUB, and compliance teams remain passionate about ensuring patients have access to life changing treatments. They work tirelessly and meticulously to design patient assistance & copay programs to ensure patient satisfaction, and prescriber confidence. The rub of course, is as brand awareness grows, so does risk exposure. So, imagine being able to ease the doubt that your programs are at risk. With a real-time holistic verification process you can: • fill the gaps seen with common eligibility checks • remain confident appropriate patients receive benefit • attenuate annual reverification challenges • focus your energies on maximizing patient and prescriber satisfaction. For the last 10 years, this unique solution has been on the leading edge of the benefit verification process. It has widespread utilization and has been verified independently by leading pharmaceutical companies and government stakeholders. Reach out to us directly or comment “learn more” below, and we will provide additional information. #patientaccess #benefitverification #HUB #pharmacy #copay TruFortis Health Solutions, LLC
Dan Newman’s Post
More Relevant Posts
-
TODAY: Don't miss ATI Advisory CEO Anne Tumlinson and Morgan Health CEO Dan Mendelson (12/12/23) at 2 p.m. ET for a dynamic discussion about the year ahead. What will be some of the challenges and opportunities for healthcare providers, payers, and patients in 2024? You can expect to hear Anne and Dan discuss value-based care, enhanced primary care, retail health, technology, and prescription drug pricing. Register Today: https://lnkd.in/ePS6GkJH #HealthPolicy #Medicare #ValueBasedCare #DrugPricing
-
-
The landscape of patient care is evolving rapidly, and virtual care is at the forefront of this revolution! 🚀 Did you know that access to virtual care is making a profound impact on patient support, especially in critical therapy areas like GI and respiratory health? 🩺 Pharmaceutical companies have a golden opportunity to stand out in the competitive market, by embracing virtual care solutions.💡 Curious to learn how? 🤔 Click here to discover the secrets of leveraging virtual care for differentiation and driving better patient outcomes 👉 https://lnkd.in/eQjz7PVU #Healthcare #VirtualCare #PatientCare #PatientCentricity #PatientExperience #Homecare #NHS
-
-
The landscape of patient care is evolving rapidly, and virtual care is at the forefront of this revolution! 🚀 Did you know that access to virtual care is making a profound impact on patient support, especially in critical therapy areas like GI and respiratory health? 🩺 Pharmaceutical companies have a golden opportunity to stand out in the competitive market, by embracing virtual care solutions.💡 Curious to learn how? 🤔 Click here to discover the secrets of leveraging virtual care for differentiation and driving better patient outcomes 👉 https://lnkd.in/eQjz7PVU #Healthcare #VirtualCare #PatientCare #PatientCentricity #PatientExperience #Homecare #NHS
-
-
So many want PBM reform but they keep using the big five! Consider the simple rule of "doing the right thing." In today's landscape, we can identify three types of Pharmacy Benefit Managers (PBMs): 1. The "big 5" PBMs prioritize driving up drug spend above all else. It's as simple as that. 2. There are a few mid-market PBMs that focus on transparency but struggle with profitability. They will not stand the test of time, operating as one-hit wonders. 3. Enter EmpiRx - our model doesn't revolve around volume; it's all about clinical excellence! Picture a dedicated team working behind the scenes, ensuring you receive the best therapy consistently. No steering towards preferred drugs, just a 100% open formulary approach. By doing what's right, everything else falls into place. Embrace the change that prioritizes better health outcomes and savings. Be bold and make a difference!
This morning, The New York Times published a devastating exposé on the traditional PBM industry. The article shines a blazing spotlight on the traditional PBM practices that prioritize rebate-driven drug volume to maximize profits. Practices like these are hurting plan sponsors, members/patients, community pharmacies, and many other stakeholders. Clearly illustrating why a clinically-driven, customer-first pharmacy care alternative is more vital than ever, below is how the NY Times described the self-dealing practices of the Big 3 PBMs: “The job of the P.B.M.s is to reduce drug costs. Instead, they frequently do the opposite. They steer patients toward pricier drugs, charge steep markups on what would otherwise be inexpensive medicines and extract billions of dollars in hidden fees, a New York Times investigation found.” Read the full article here. https://lnkd.in/eU6p-vFb EmpiRx Health’s clinically-driven pharmacy care approach is by far the best alternative to the legacy PBMs, who prioritize their own profits at the expense of their customers. Want to learn more about why plan sponsors and their advisors and consultants are increasingly choosing EmpiRx Health for their pharmacy benefits care? Contact us today! https://lnkd.in/eeiGZpxM #PBM #Healthcare #NewYorkTimes
-
-
Marketing and Communications Veteran, Helping Clients to Build Leadership Brands, Grow and Win
Today's NY Times article really told the tale of how the big 3 legacy PBMs have so negatively impacted the healthcare system writ large. Please read the Times article and let us know what you think.
This morning, The New York Times published a devastating exposé on the traditional PBM industry. The article shines a blazing spotlight on the traditional PBM practices that prioritize rebate-driven drug volume to maximize profits. Practices like these are hurting plan sponsors, members/patients, community pharmacies, and many other stakeholders. Clearly illustrating why a clinically-driven, customer-first pharmacy care alternative is more vital than ever, below is how the NY Times described the self-dealing practices of the Big 3 PBMs: “The job of the P.B.M.s is to reduce drug costs. Instead, they frequently do the opposite. They steer patients toward pricier drugs, charge steep markups on what would otherwise be inexpensive medicines and extract billions of dollars in hidden fees, a New York Times investigation found.” Read the full article here. https://lnkd.in/eU6p-vFb EmpiRx Health's clinically-driven pharmacy care approach is by far the best alternative to the legacy PBMs, who prioritize their own profits at the expense of their customers. Want to learn more about why plan sponsors and their advisors and consultants are increasingly choosing EmpiRx Health for their pharmacy benefits care? Contact us today! https://lnkd.in/eeiGZpxM #PBM #Healthcare #NewYorkTimes
-
-
Marketing and Communications Veteran, Helping Clients to Build Leadership Brands, Grow and Win
This NY Times article really captures the breadth and depth of the incredibly negative impact of the Big 3 PBM players on the healthcare system, especially the plan sponsors and their members. There is a better way, and it is the clinically-driven pharmacy care provided by EmpiRx Health. Check it out!
This morning, The New York Times published a devastating exposé on the traditional PBM industry. The article shines a blazing spotlight on the traditional PBM practices that prioritize rebate-driven drug volume to maximize profits. Practices like these are hurting plan sponsors, members/patients, community pharmacies, and many other stakeholders. Clearly illustrating why a clinically-driven, customer-first pharmacy care alternative is more vital than ever, below is how the NY Times described the self-dealing practices of the Big 3 PBMs: “The job of the P.B.M.s is to reduce drug costs. Instead, they frequently do the opposite. They steer patients toward pricier drugs, charge steep markups on what would otherwise be inexpensive medicines and extract billions of dollars in hidden fees, a New York Times investigation found.” Read the full article here. https://lnkd.in/eU6p-vFb EmpiRx Health’s clinically-driven pharmacy care approach is by far the best alternative to the legacy PBMs, who prioritize their own profits at the expense of their customers. Want to learn more about why plan sponsors and their advisors and consultants are increasingly choosing EmpiRx Health for their pharmacy benefits care? Contact us today! https://lnkd.in/eeiGZpxM #PBM #Healthcare #NewYorkTimes
-
-
This morning, The New York Times published a devastating exposé on the traditional PBM industry. The article shines a blazing spotlight on the traditional PBM practices that prioritize rebate-driven drug volume to maximize profits. Practices like these are hurting plan sponsors, members/patients, community pharmacies, and many other stakeholders. Clearly illustrating why a clinically-driven, customer-first pharmacy care alternative is more vital than ever, below is how the NY Times described the self-dealing practices of the Big 3 PBMs: “The job of the P.B.M.s is to reduce drug costs. Instead, they frequently do the opposite. They steer patients toward pricier drugs, charge steep markups on what would otherwise be inexpensive medicines and extract billions of dollars in hidden fees, a New York Times investigation found.” Read the full article here. https://lnkd.in/eU6p-vFb EmpiRx Health’s clinically-driven pharmacy care approach is by far the best alternative to the legacy PBMs, who prioritize their own profits at the expense of their customers. Want to learn more about why plan sponsors and their advisors and consultants are increasingly choosing EmpiRx Health for their pharmacy benefits care? Contact us today! https://lnkd.in/eeiGZpxM #PBM #Healthcare #NewYorkTimes
-
-
Employers and business owners who are tired of the traditional PBM experience need to read this article.
This morning, The New York Times published a devastating exposé on the traditional PBM industry. The article shines a blazing spotlight on the traditional PBM practices that prioritize rebate-driven drug volume to maximize profits. Practices like these are hurting plan sponsors, members/patients, community pharmacies, and many other stakeholders. Clearly illustrating why a clinically-driven, customer-first pharmacy care alternative is more vital than ever, below is how the NY Times described the self-dealing practices of the Big 3 PBMs: “The job of the P.B.M.s is to reduce drug costs. Instead, they frequently do the opposite. They steer patients toward pricier drugs, charge steep markups on what would otherwise be inexpensive medicines and extract billions of dollars in hidden fees, a New York Times investigation found.” Read the full article here. https://lnkd.in/eU6p-vFb EmpiRx Health’s clinically-driven pharmacy care approach is by far the best alternative to the legacy PBMs, who prioritize their own profits at the expense of their customers. Want to learn more about why plan sponsors and their advisors and consultants are increasingly choosing EmpiRx Health for their pharmacy benefits care? Contact us today! https://lnkd.in/eeiGZpxM #PBM #Healthcare #NewYorkTimes
-
